SynuSight Biotech, ABLi Therapeutics and XingImaging Announce Strategic Collaboration to Implement Alpha-Synuclein PET Imaging into Clinical Trials Evaluating Risvodetinib as a Disease-modifying Therapy for Parkinson's Disease GlobeNewswire January 05, 2026 SynuSight Biotech has licensed 18F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment SHANGHAI and […]

Kriya Appoints Sachiyo Minegishi as Chief Financial Officer Seasoned biotech executive with a track record of guiding corporate development, financial strategy and commercialization for public and private biopharma companies GlobeNewswire January 05, 2026 RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2026 (GLOBE NEWSWIRE) — Kriya Therapeutics, Inc. (“Kriya”), a clinical-stage biopharmaceutical company developing life-changing gene therapies

Weight Watchers Expands Its Integrated GLP-1 Platform with Access to Wegovy(R) Pill Advancing a New Standard for Long-Term Weight Health A NovoCare(R) Recognized Care Provider, Weight Watchers' new Med+ program delivers an integrated GLP-1 care model proven to drive greater weight loss results than medication alone GlobeNewswire January 05, 2026 NEW YORK, Jan. 05, 2026

Kailera Therapeutics Appoints Doug Pagan as Chief Financial Officer GlobeNewswire January 05, 2026 — Proven financial and strategic leader with over two decades of experience driving organizational growth, operational excellence, and longâ€'term value creation — WALTHAM, Mass. and SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) — Kailera Therapeutics, Inc., an advanced clinical-stage biotechnology company focused

TANAKA PRECIOUS METAL GROUP Co., Ltd. (Head office: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka) announces that it has finalized the executive appointments for TANAKA PRECIOUS METAL NEXT Co., Ltd., a new company established on January 5, 2026. TANAKA's Executive Appointments 1. TANAKA PRECIOUS METAL GROUP Co., Ltd. (Effective January 5, 2026) New Position: –Name: Tomohiro

Caption: 2025 Kailas FUGA Shenzhen 100 Mountain Trail SHENZHEN, China, Jan. 05, 2026 (GLOBE NEWSWIRE) — The 2025 Kailas FUGA Shenzhen 100 Mountain Trail and TORX(R) CHN 100 saw new course records in what was the largest and fastest edition of the race since it launched in 2023. This year welcomed 191 elite athletes and

(NASDAQ:CPRX), CORAL GABLES, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) — The University of Notre Dame and Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced their inaugural Catalyst Advocacy Scholars Summit (CASS). This one-of-a-kind

2025 Kailas FUGA Shenzhen 100 & TORX(R) CHN 100 Sets New Records China's Top City Trail Race Welcomes Almost 6,000 Runners GlobeNewswire January 05, 2026 Caption: 2025 Kailas FUGA Shenzhen 100 Mountain Trail SHENZHEN, China, Jan. 05, 2026 (GLOBE NEWSWIRE) — The 2025 Kailas FUGA Shenzhen 100 Mountain Trail and TORX(R) CHN 100 saw new

The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS) Students from The University of Notre Dame Selected to Participate in a Week-long Biopharmaceutical Learning Intensive GlobeNewswire January 05, 2026 CORAL GABLES, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) — The University of Notre Dame and Catalyst Pharmaceuticals, Inc. (“Catalyst” or

(NasdaqGM:WLFC), COCONUT CREEK, Fla. and NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) — Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and a global provider of aviation services, and Blackstone Credit & Insurance (“BXCI”) announced a strategic aircraft engine leasing partnership with plans to deploy over